The effects of vaccination in an age-dependent model for varicella and herpes zoster

IEEE Transactions on Automatic Control

Volumn 43, Issue 6, 1998, Pages 779-789

  Allen, Linda J S ^a   Thrasher, David B ^a  

^a TEXAS TECH UNIVERSITY   (United States)

Author keywords

Chicken pox; Open loop control; SIR epidemic model; Vaccination

Indexed keywords

DISEASE CONTROL; EPIDEMIOLOGY; MATHEMATICAL MODELS; VACCINES;

CHICKEN POX; SHINGLES;

CONTROL;

EID: 0032096938     PISSN: 00189286     EISSN: None     Source Type: Journal    
DOI: 10.1109/9.679018     Document Type: Article

References (42)

1. R. M. Anderson and R. M. May, Infectious Diseases of Humans Dynamics and Control. Oxford, U.K.: Oxford Univ. Press, 1992.
2. N. G. Becker and V. Rouderfer, "Simultaneous control of measles and rubella by multidose vaccination schedules," Math. Biosci., vol. 131, pp. 81-102, 1996.
3. A. S. Benenson, Ed., Control of Communicable Diseases in Man, 14th ed. Washington, DC: American Public Health Assn., 1985.
4. P. A. Brunell, J.-T. Wiedeman, C. F. Geiser, L. Frierson, and E. Lydick, "Risk of herpes zoster in children with leukemia: Varicella vaccine compared with history of chickenpox," Pediatrics, vol. 77, pp. 53-56, 1986.
5. C. Castillo-Chavez, H. W. Hethcote, V. Andreasen, S. A. Levin, and W. M. Liu, "Epidemiological models with age structure, proportionate mixing, and cross immunity," J. Math. Biol., vol. 27, pp. 233-258, 1989.
6. Centers for Disease Control and Prevention, "Prevention of varicella - Recommendations of the Advisory Committee on Immunization Practices (ACIP)," MMWR, vol. 45, no. RR-11, pp. 1-36, 1996.
7. L. Coletti and D. da Costa, Eds, "FDA approves first chickenpox vaccine in U.S.," VZV Focus, The Newsletter of the VZV Res. Found., vol. III. no. 1, pp. 1, 2, 1995.
8. Committee on Infectious Diseases, Report of the Committee on Infectious Diseases, G. Peter, Ed., 21st ed. Elk Grove Village, IL: American Academy of Pediatrics, 1988.
9. N. M. Ferguson, R. M. Anderson, and G. P. Garnett, "Mass vaccination to control chickenpox: The influence of zoster," in Proc. Nat. Acad. Sci., 1996, vol. 93, pp. 7231-7235.
10. G. P. Garnett and B. T. Grenfell, "The epidemiology of varicella-zoster virus infections: A mathematical model," Epidemiol. Infect., vol. 108, pp. 495-511, 1992.
11. _, "The epidemiology of varicella-zoster virus infections: The influence of varicella on the prevalence of herpes zoster," Epidemiol. Infect., vol. 108, pp. 513-528, 1992.
12. A. A. Gershon, P. LaRussa, I. Hardy, S. Steinberg, and S. Silverstein, "Varicella vaccine: The American experience," J. Infect. Dis, vol. 166, no. Suppl. 1, pp. S53-S68, 1992.
13. A. A. Gershon, P. LaRussa, S. Steinberg, N. Mervish, S. H. Lo, and P. Meier, "The protective effect of immunologic boosting against zoster: An analysis in leukemic children who were vaccinated against chickenpox," J. Infect. Dis., vol. 173, pp. 450-453, 1996.
14. A. A. Gershon and S. Steinberg, "NIAID collaborative varicella vaccine study group: Persistence of immunity to varicella in children with leukemia immunized with live attenuated varicella vaccine," N. Engl. J. Med, vol. 320, pp. 892-897, 1989.
15. D. H. Gilden, "Herpeszoster with postherpetic neuralgia-persisting pain and frustration," N. Engl. J. Med., vol. 330, no. 13, pp. 932-934, 1994.
16. C. Grose and R. H. Giller, "Varicella-zoster virus infection and immunization in the healthy and the immunocompromised host," CRC Critical Rev. Oncology/Hematology, vol. 8, pp. 27-64, 1988.
17. K. P. Hadeler and J. Müller, "Vaccination in age structured populations I: The reproduction number," in Models for Infectious Human Diseases - Their Structure and Relation to Data, V. Isham and G. Medley, Eds Cambridge, U.K.: Cambridge Univ. Press, 1996, pp. 90-101.
18. _, "Vaccination in age structured populations II: Optimal strategies," in Models for Infectious Human Diseases Their Structure and Relation to Data, V. Isham and G. Medley, Eds. Cambridge, U.K.: Cambridge Univ. Press, 1996, pp. 102-114.
19. M. E. Halloran, S. L. Cochi, T. A. Lieu, M. Wharton, and L. Fehrs, "Theoretical epidemiologic and morbidity effects of routine varicella immunization of preschool children in the United States," Am. J. Epid., vol. 140, pp. 81-104, 1994.
20. M. E. Halloran, L. Watelet, and C. J. Struchiner, "Epidemiological effects of vaccines with complex direct effects in an age-structured population," Math. Biosci., vol. 121, pp. 193-225, 1994.
21. A. Hayward, M. Levin, W. Wolf, G. Angelova, and D. Gilden, "Varicella-zoster virus-specific immunity after herpes zoster," J. Infect. Dis., vol. 163, pp. 873-875, 1991.
22. R. E. Hope-Simpson, "The nature of herpes-zoster: A long-term study and a new hypothesis," in Proc. Roy Soc. Med., 1965, vol. 58, pp. 9-20.
23. F. Hoppensteadt, "Mathematical theories of populations Demographics, genetics and epidemics," Regional Conf. Series in Appl. Math. Philadelphia, PA: SIAM, 1975.
24. M. Just, R. Berger, and D. Luescher, "Live varicella vaccine in healthy individuals," Postgrad. Med. J., vol. 61, no. Suppl. 4, pp. 129-132, 1985.
25. T. A. Lieu, S. L. Cochi, S. B. Black, M. E. Halloran, H. R. Shinefield, S. J. Holmes, M. Wharton, and E. Washington, "Cost-effectiveness of a routine varicella vaccination program for US children," JAMA, vol. 271, pp. 375-381, 1994.
26. S. Nader, Bergen, R. M. Sharp, and A. M. Arvin, "Age-related differences in cell-mediated immunity to varicella-zoster virus among children and adults immunized with live attenuated varicella vaccine," J. Infect. Dis., vol. 171, pp. 13-17, 1995.
27. D. P. Noga, "The effect of varicella vaccination on the average age of infection," Master's thesis, Texas Tech Univ., Lubbock, TX, 1995.
28. E. C. Pielou, Mathematical Ecology. New York, Wiley, 1977.
29. S. A. Plotkin, "Clinical and pathogenic aspects of varicella-zoster," Postgrad. Med. J., vol. 61, no. Suppl. 4, pp. 7-14, 1985.
30. _, "Vaccines for varicella-zoster virus and cytomegalovirus: Recent progress," Science, vol. 265, pp. 1383-1385, 1994.
31. S. A. Plotkin, A. A. Arbetter, and S. E. Starr, "The future of varicella vaccine," Postgrad. Med. J., vol. 61, no. Suppl. 4, pp. 155-162, 1985.
32. M. W. Ragozzino, L. J. Melton, III, L. T. Kurland, C. P. Chu, and H. O. Perry, "Population-based study of herpes zoster and its sequelae," Medicine, vol. 61, no. 5, pp. 310-316, 1982.
33. V. Rouderfer and N. G. Becker, "Assessment of two-dose vaccination schedules: Availability for vaccination and catch-up strategies," Math. Biosci., vol. 129, pp. 41-66, 1995.
34. V. Rouderfer, N. G. Becker, and H. W. Hethcote, "Waning immunity and its effects on vaccination schedules," Math. Biosci., vol. 124, pp. 59-82, 1994.
35. M. Takahashi, "Clinical overview of varicella vaccine: Development and early studies," Pediatrics, vol. 78, no. Suppl., pp. 736-741, 1986.
36. M. Takahashi, T. Iketani, K. Sasada, J. Hara, H. Kamiya, Y. Asano, K. Baba, and K. Shiraki, "Immunization of the elderly and patients with collagen vascular diseases with live varicella vaccine and use of varicella skin antigen," vol. 165, no. Suppl. 1, pp. S58-S62, 1992.
37. T. C. Thomsen, Shingles and PHN. New York: Cross River Press, 1994.
38. U. S. Bureau of the Census, Statistical Abstracts of the United States. Washington, DC: Government Printing Office, 1994.
39. D. B. Thrasher, "Optimal vaccination strategies for varicella and herpes zoster," Master's thesis, Texas Tech Univ., Lubbock, TX, 1996.
40. B. Watson, R. Gupta, T. Randall, and S. Starr, "Persistence of cell-mediated and humoral immune responses in healthy children immunized with live attenuated varicella vaccine," J. Infect. Dis., vol. 169, pp. 197-199, 1994.
41. T. H. Weller, "Varicella and herpeszoster: A perspective and overview," J. Infect. Dis., vol. 165, pp. S1-S6, 1992.
42. R. J. Whitley, "Therapeutic approaches to varicella zoster virus infection," J. Infect. Dis., vol. 165, pp. S51-S57, 1992.